beta
JUNO
Juno Therapeutics Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Juno Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in developing products that use human cells as therapeutic entities and, although there have been significant advances in cell-based immunotherapy.
Market Cap: 9.89 Billion
Primary Exchange: Nasdaq Global Select
Website: http://www.junotherapeutics.com
Shares Outstanding: 115 Million
Float: 109 Million
Dividend: 0.0 (0.0%)
Beta: 3.500534
Sector: Healthcare
Industry: Biotechnology
Ethical Flags
Longest drawdown: 658 trading days
From: 2015-06-05 To: 2018-01-16
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|